Buy Cyclerion Therapeutics,Inc. Stock | CYCNV Stock Price & Latest News | Public.com
CYCNV

Cyclerion Therapeutics,Inc.

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Cyclerion Therapeutics,Inc. (CYCNV) stock trends here

    About CYCNV

    Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pip...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$133,8M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.96
    1 Year Low$2.08
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app